Dr. Gaurav Dixit

MBBS, MD (Medicine), DM (Clinical Hematology)

Chief – Bone Marrow Transplant & Hematology

16+ Years of Experience
Gurgaon

Dr. Gaurav Dixit is an exceptionally brilliant, highly dynamic senior hematologist and bone marrow transplant (BMT) specialist. Holding a premier DM in Clinical Hematology from a prestigious central central medical institute, Dr. Dixit represents the absolute peak tier of ultra-precision blood cancer management and stem cell therapeutics in the region. He is globally sought after for his technical mastery in performing complex allogeneic BMTs, haploidentical (half-matched) transplants, and managing treatment-resistant bone marrow failure syndromes. Known for his deeply analytical mind and meticulous infection-control protocols, he designs highly protective, clean-room strategies for patients undergoing high-dose chemotherapy lines.

  • Allogeneic Stem Cell Transplantation: High-precision HLA-matched and haploidentical transplants for acute leukemias and high-risk myelodysplastic syndromes.
  • Autologous Bone Marrow Transplants: Stem cell transplantation tracks for multiple myeloma, Hodgkin’s and non-Hodgkin’s lymphomas.
  • Aplastic Anemia & Thalassemia Transplants: Curative cellular transplant protocols for pediatric and young adult patients with severe bone marrow failures.
  • Advanced CAR-T Cell Therapy Candidate Mapping: Molecular screening and preparation for next-generation cellular immunotherapies.
  • Successfully executed over 400 complex bone marrow transplants with excellent long-term engraftment metrics and low graft-versus-host disease (GVHD) indices.
  • Played a monumental, central role in designing and operationalizing the advanced, HEPA-filtered tertiary BMT suites at Artemis.
  • Published extensive research in indexed global hematology journals focusing on reducing post-transplant viral reactivation pathways.
  • Honored with multiple young investigator awards and clinical excellence recognitions at international hematology conventions.
  • Active fellow of the Indian Society of Hematology and Blood Transfusion (ISHBT) and the American Society of Hematology (ASH).